Navigation Links
Jazz Pharmaceuticals Announces Participation At Two Investor Conferences In March
Date:2/27/2013

DUBLIN, Feb. 27, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that the company will participate in two upcoming investor conferences.  A live webcast of each presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com.  The conferences, presentation times and speakers include:

  • Cowen and Company 33rd Annual Healthcare Conference in Boston, MA on Wednesday, March 6, 2013 at 8:40 a.m. EST/1:40 p.m. GMT.  Kathryn Falberg, executive vice president and chief financial officer, will provide a business update.   
  • Barclays Global Healthcare Conference in Miami, FL on Tuesday, March 12, 2013 at 9:00 a.m. EST/2:00 p.m. GMT.  Bruce Cozadd, chairman and chief executive officer, will provide a business update. 

An archived version of each webcast will be available for at least one week following each respective presentation on the Investors section of the company's website at www.jazzpharmaceuticals.com.

About Jazz Pharmaceuticals

Jazz Pharmaceuticals plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing innovative products that address unmet medical needs.  The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.  The company's U.S. marketed products in these areas include: Xyrem® (sodium oxybate) oral solution, Erwinaze® (asparaginase Erwinia chrysanthemi), Prialt® (ziconotide) intrathecal infusion, Luvox CR® (fluvoxamine maleate), FazaClo® (clozapine, USP) HD and FazaClo LD.  Outside of the U.S., Jazz Pharmaceuticals also has a number of products marketed by its EUSA Pharma division.  For further information, see www.jazzpharmaceuticals.com.


'/>"/>
SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... -- Andre, DiMino, CEO of ADM Tronics Unlimited, Inc. (OTCQB: ... and products, commented on ADMT,s third quarter fiscal year ... the Company,s quarterly report on Form 10Q available at ... stated "During the quarter ended December 31, 2016 we ... portion of our engineering efforts into the development of ...
(Date:2/22/2017)... VANCOUVER, Feb. 22, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) ... for the quarter and full fiscal year ended December 31, ... ... the Company,s audited financial statements and management discussion and analysis ... have been filed on SEDAR and are available at ...
(Date:2/22/2017)... , Feb. 22, 2017 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... host its Fourth Quarter 2016 investor conference call and webcast ... The call will cover an update on Merrimack,s ... and full year 2016 financial results. A press release detailing ... issued the morning of Wednesday, March 1. Investors and the ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... Sideline Products participated in the ... national TV host Tom Seay and his production crew. Tom Seay’s program “Best ... around the world. Saddle Sidekicks will be featured on April 6, 2017. After ...
(Date:2/22/2017)... ... 2017 , ... The Centers for Medicare & Medicaid Services ... Delaware, New Jersey, Pennsylvania and West Virginia prepare for and participate in the ... of 2015 (MACRA). , This technical assistance, authorized and funded under MACRA, ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... 72 percent of those report that family members or friends have also commented ... suffer from hearing loss wear hearing aids. One reason, suggested by 89 percent ...
(Date:2/22/2017)... ... February 22, 2017 , ... FPS ... from combat-related PTSD. , Established in 1977, our organization was at the forefront ... military returning to civilian life were evident and served as the catalyst for ...
(Date:2/22/2017)... ... 22, 2017 , ... Apptricity® Corporation, a leading global provider ... today announced that Keppel Corporation has selected Apptricity Travel and Expense Management integrated ... are excited to announce the partnership between Keppel and Apptricity for our Global ...
Breaking Medicine News(10 mins):